Heparin
Therapy for Burns
FOR
DOCTORS ONLY
ALL DOCTORS CAN NOW TREAT BURNS WITH HEPARIN
PATIENTS RECEIVE PROMPT TREATMENT BY THEIR PRIMARY DOCTORS.
PEDIATRICIANS, FAMILY DRS, INTERNISTS, ALL SPECIALISTS AND ER DOCTORS
When
your burned patient in much pain seeks your help, and you drip or spray
heparin solution on the painful raw burn surface, the pain will be relieved
within a few minutes, and the angry redness will blanche. Then, when
you insert heparin solution into painful blisters and rinse the blister
with the heparin solution, the blister pain will be relieved in less
than a minute. The burn surface and blisters will not be as warm. Your
patient and you will recognize that you have initiated prompt effective
therapy. You will not need to administer any ‘pain medicine’.
Heparin stopped pain and initiated burn therapy. In fact 3 of the 4
four signs of inflammation (pain, redness, and heat) will be gone.
If and when the patient’s burn surface pain returns in a lesser
amount after a variable period of time, retreatment of the less painful
burn surface by dripping or spraying heparin on the burn surface will
again relieve the pain. With continued use of heparin, the 4th sign
of inflammation, namely swelling, that is common to burns not treated
with heparin will be much less. It may be absent. Heparin stops burn
inflammation. And with less swelling, there will be little or no need
for surgical incisions to relieve pressure in swollen tissue compartments.
For patients who additionally have a vague deeper pain, intravenous
infusion of heparin solution rapidly relieves the pain and blanches
the erythema if it is present. Subcutaneous deposit of heparin solution
into fat more slowly relieves the pain and blanches erythema.
No pain medicine will be needed. Unlike burned patients who receive
sedating pain medicine, like morphine, heparin treated patients are
comfortable, awake, alert, without depression of respirations or intestinal
movements. Patients have less or no swelling. They are able to drink
fluids and to eat. They are able to be more physically active and even
to assist with their treatment. (See Protocol Link for details of Method.
See Case Studies pictures to see patients’ condition.)
WITH CONTINUED USE OF HEPARIN, ACCORDING TO THE PROTOCOL THE OTHER BENEFITS
WILL BE OBSERVED.
ALL OTHER TREATMENT METHODS ARE COMPATIBLE WITH INITIAL USE OF HEPARIN,
INCLUDING SURGERY, slightly delayed in lesser amount when needed and
when necessary.
ALL DOCTORS CAN INITIALLY SEE THEIR BURNED PATIENTS AND LATER WHEN NECESSARY
REFER THEIR PATIENTS TO BURN SPECIALISTS. Plastic surgeons do the plastic
surgery when needed, which is the most efficient use of their time and
talents and hence they are not burdened with the early burn care.
Adding heparin improves treatment, reduces procedures, and makes cost
affordable and sustainable. Use of heparin first reduces and avoids
the loss of blood common with use of surgery first to remove most or
all of the burned tissue and place skin substitute or skin grafts. With
little or no loss of blood, there is little or no need for blood transfusions,
and no danger of transmitting disease through blood, such as AIDS. With
early first use of heparin the burn wound site is ideally prepared with
richly vascular granulation tissue most favorable for placing skin grafts
with a higher % of the successful graft ‘take’.
With continued use of heparin topically into healing the skin cosmetic
results are much improved, usually void of scars and contractures. (See
Science of Heparin Use.)
Adding heparin to burn treatment has made treatment of burns affordable
worldwide.
SUMMARY FOR DOCTORS
Heparin is precise therapy for the concise pathology of burns. The
known sequential multiple burn-pathology stages and the sequential
known multiple heparin properties-and-effects healing stages are a
perfect therapeutic match. Similarly heparin is a therapeutic match
for the pathology stages of chronic wounds and difficult to treat
chronic skin problems. Burn Pathology Phases involve:
(1) sluggish blood flow with coagulation, infarctions, emboli, and
DIC;
(2) cascading tissue-destructive inflammation;
(3) ischemia and gangrene;
(4) delayed and deficient granulation
(5) inadequate replacement of collagen and smooth muscle and skin
tissue-cells, and
(6) disrupted epithelialization with scars and contractures.
Heparin’s
matching Therapeutic Effects are
(1) anticoagulating;
(2) anti-inflammatory;
(3) neoangiogenic-revascularizing
(4) collagen restoring-regulating,
(5) smooth muscle cell and dermal cell stimulating-regulating; and
(5) epithelializing with dermal cells that results in smooth skin
consistently void of scars or contractures. Heparin effects and properties
therapeutically stops, reverses, corrects, favorably alters, stimulates,
replaces, regulates, and heals the corresponding matching burn pathology
phases.
Heparin use first, when not contraindicated, is compatible with other
therapy methods, including surgery - slightly delayed, in less quantity,
under more favorable conditions.
Heparin produces richly-vascular granulation tissue ideal for successful
skin grafting or skin cell implant with the patients own cultured
skin cells. The initial nearly total surgical resection of the burn
under anesthesia via intubation, with blood loss and transfusions
is not necessary. Using heparin first, the patients are not toxic,
mortality is not increased – it is decreased, blood loss and
transfusions are eliminated, much medical healing of burns is achieved,
and the need to cover the denuded area with skin grafts or artificial
membranes is often avoided.
Healing is complete in many patients with use of heparin alone, especially
in children. Patients requiring surgery or in cases where surgery
is desirable can still have surgery by stopping heparin for 1 to 2
days, or rarely 3 days until Blood Clotting Times return to the normal
range.
Heparin is ideal for use in one burned person or the many burned in
Thermal Disasters. In a thermal disaster, heparin sprayed on burns
and in blisters would cost-effectively promptly relieve pain, stop
inflammation, and initiate affordable therapy as a first-response
workable treatment, where no cost-effective therapy is now available.